HOOK - HOOKIPA Pharma Inc.
1.61
0.130 8.075%
Share volume: 153,556
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.48
0.13
0.09%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-11-2023 | 08-10-2023 | 11-09-2023 | 03-22-2024 | 05-09-2024 | 08-08-2024 | 11-14-2024 | 02-27-2025 | |
| Total revenue | 3.176 M | 2.679 M | 6.867 M | 7.407 M | 36.599 M | 1.290 M | 4.703 M | 1.354 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 3.176 M | 2.679 M | 6.867 M | 7.407 M | 36.599 M | 1.290 M | 4.703 M | 1.354 M | |
| -15.65% | 156.33% | 7.86% | 394.11% | -96.48% | 264.57% | -71.21% | |||
| Operating expenses | 25.833 M | 24.151 M | 29.537 M | 25.536 M | 24.224 M | 23.694 M | 22.297 M | 18.518 M | |
| Selling general and admin | 4.902 M | 4.445 M | 4.912 M | 4.374 M | 4.056 M | 3.945 M | 6.732 M | 5.493 M | |
| Research and development | 20.931 M | 19.706 M | 24.625 M | 21.162 M | 20.168 M | 19.749 M | 15.565 M | 13.025 M | |
| Total expenses | 25.833 M | 24.151 M | 29.537 M | 25.536 M | 25.493 M | 23.748 M | 23.347 M | 22.813 M | |
| -6.51% | 22.30% | -13.55% | -0.17% | -6.85% | -1.69% | -2.29% | |||
| Operating income | -22.657 M | -21.472 M | -22.670 M | -18.129 M | 11.106 M | -22.458 M | -18.644 M | -21.459 M | |
| Ebit | -22.657 M | -21.472 M | -22.670 M | -18.129 M | 13.054 M | -20.168 M | -14.650 M | -25.544 M | |
| Pretax income | -19.475 M | -18.016 M | -19.066 M | -24.655 M | 14.383 M | -19.095 M | -13.841 M | -25.056 M | |
| -7.49% | 5.83% | 29.31% | -158.34% | -232.76% | -27.52% | 81.03% | |||
| Income tax | 205.000 K | 0.000 | 0.000 | 163.000 K | 0.000 | 0.000 | 0.000 | -106.000 K | |
| Net income basic | -19.680 M | -18.016 M | -19.066 M | -24.818 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| 8.46% | -5.83% | -30.17% | 100.00% | ||||||
| Net income | -19.680 M | -18.016 M | -19.066 M | -24.818 M | 14.383 M | -19.095 M | -13.841 M | -24.950 M | |
| 8.46% | -5.83% | -30.17% | 157.95% | -232.76% | 27.52% | -80.26% |
